Detailed answers about BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED, including incorporation, status, business activity, and accounts information.
When was BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED founded?
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED was officially incorporated on 2 April 1990 and is registered under company number 02487574. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED?
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED do?
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED operates in the following sector: 21100 - Manufacture of basic pharmaceutical products. This provides insight into the company's primary business activity and industry focus.
What is BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED's registered address?
The registered office address of BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED is ARC UXBRIDGE SANDERSON ROAD, NEW DENHAM, DENHAM, BUCKINGHAMSHIRE, UNITED KINGDOM, UB8 1DH. This is the official address filed with Companies House for legal and statutory correspondence.
Is BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED financially stable?
The most recent accounts for BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED were made up to 31 December 2024, filed as FULL. Next accounts are due by 30 September 2026.